ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials.
Macquarie Bank names new CEO
subscribe
A
A
Macquarie has announced that it will welcome a new managing director and CEO following the retirement of Mary Reemst.
After 22 years with Macquarie, Mary Reemst has decided to retire from her role as managing director and CEO of Macquarie Bank Ltd (MBL), from the MBL board, from Macquarie Group Ltd (MGL) and MBL executive committees, effective 1 July 2021.
Ms Reemst, who has been on the executive committees for seven years, also serves as the chair of the Macquarie Group Foundation.
From 1 July 2021, and subject to regulatory approvals, Stuart Green will become managing director and CEO of MBL, and join the MBL board and MGL and MBL executive committees.